A Locus on Chromosome 7 Determines Dramatic Up-Regulation of Osteopontin in Dystrophic Cardiac Calcification in Mice

American Journal of Pathology

Volumn 164, Issue 4, 2004, Pages 1379-1387

  Aherrahrou, Zouhair ^a   Axtner, Susanne B ^a   Kaczmarek, Piotr M ^a   Jurat, Alexandra ^a   Korff, Susanne ^b   Doehring, Lars C ^a   Weichenhan, Dieter ^b   Katus, Hugo A ^b   Ivandic, Boris T ^b,c  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c Medizinische Klinik III   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; OSTEOPONTIN; TRANSFORMING GROWTH FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CALCINOSIS; CHROMOSOME 7; CONTROLLED STUDY; DNA POLYMORPHISM; DYSTROPHIC CARDIAC CALCIFICATION; FEMALE; GENE LOCUS; GENETIC TRANSCRIPTION; HEART DISEASE; HEART INJURY; HEART MUSCLE; INFLAMMATION; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SEQUENCE ANALYSIS;

EID: 1642352650     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63224-5     Document Type: Article

References (56)

1. Beadenkopf WG, Daoud AS, Love BM: Calcification in the coronary arteries and its relationship to arteriosclerosis and myocardial infarction. Am J Roentgenof 1964, 92:865-871
2. Niskanen LK, Suhonen M, Siitonen O, Lehtinen JM, Uusitupa MI: Aortic and lower limb artery calcification in type II (non-insulin-dependent) diabetic patients and non-diabetic control subjects: a five year follow-up study. Atherosclerosis 1990, 84:61-71
3. Lehto S, Niskanen LK, Suhonen L, Ronnemaa T, Laakso M: Medial artery calcification: a neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol 1996, 16:978-983
4. Anderson HC: Matrix vesicle calcification: review and update. Bone and Mineral Research. Chicago, Elsevier Science Publishers, 1985
5. Boskey AL: Matrix proteins and mineralization: an overview. Connect Tissue Res 1996, 35:357-363
6. Gorski JP: Acidic phosphoproteins from bone matrix: a structural rationalization of their role in biomineralization. Calcif Tissue Int 1992, 50:391-396
7. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer R, Karsenty G: Spontaneous calcification of arteries and cartilage in mice lacking matrix Gla protein. Nature 1997, 386:78-81
8. Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lacey DL, Boyle WJ, Simonet WS: Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 1998, 12:1260-1268
9. Steitz SA, Speer MY, McKee MD, Liaw L, Almeida M, Yang H, Giachelli CM: Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification. Am J Pathol 2002, 161:2035-2046
10. Shanahan CM, Cary NRB, Metcalfe JC, Weissberg PL: High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J Clin Invest 1994, 93:2393-2402
11. Bini A, Mann KG, Kudryk BJ, Schoen FJ: Non-collagenous bone matrix proteins, calcification, and thrombosis in carotid artery atherosclerosis. Arterioscler Thromb Vasc Biol 1999, 19:1852-1861
12. Giachelli CM, Bae N, Almeida M, Denhardt DT, Alpers CE, Schwartz SM: Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest 1993, 92:1686-1696
13. Mohler ER, Adam LP, McClelland P, Graham L, Hathaway DR: Detection of osteopontin in calcified human aortic valves. Arterioscler Thromb Vasc Biol 1997, 17:547-552
14. Shanahan CM, Cary NR, Salisbury JR, Proudfoot D, Weissberg PL, Edmonds ME: Medial localization of mineralization-regulating proteins in association with Monckeberg's sclerosis: evidence for smooth muscle cell-mediated vascular calcification. Circulation 1999, 100: 2168-2176
15. Singh K, DeVouge MW, Mukherjee BB: Physiological properties and differential glycosylation of phosphorylated and nonphosphorylated forms of osteopontin secreted by normal rat kidney cells. J Biol Chem 1990, 265:18696-18701
16. Beninati S, Senger DR, Cordella-Miele E, Mukherjee AB, Chackalaparampil I, Shanmugam V, Singh K, Mukherjee BB: Osteopontin: its transglutaminase-catalyzed posttranslational modifications and cross-linking to fibronectin. J Biochem 1994, 115:675-682
17. Jono S, Peinado C, Giachelli CM: Phosphorylation of osteopontin is required for inhibition of vascular smooth muscle cell calcification. J Biol Chem 2000, 275:20197-20203
18. Oldberg A, Franzen A, Heinegard D: Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc Natl Acad Sci USA 1986, 83:8819-8823
19. Denhardt DT, Giachelli CM, Rittling SR: Role of osteopontin in cellular signaling and toxicant injury. Annu Rev Pharmacol Toxicol 2001, 41:723-749
20. Giachelli CM, Lombardi D, Johnson RJ, Murry CE, Almeida M: Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am J Pathol 1998, 152:353-358
21. Reinholt FP, Hultenby K, Oldberg A, Heinegard D: Osteopontin - a possible anchor of osteoclasts to bone. Proc Natl Acad Sci USA 1990, 87:4473-4475
22. Murry CE, Giachelli CM, Schwartz SM, Vracko R: Macrophages express osteopontin during repair of myocardial necrosis. Am J Pathol 1994, 145:1450-1462
23. McConnel BK, Jones KA, Fatkin D, Arroyo LH, Lee RT, Aristizabal O, Turnbull DH, Georgakopoulos D, Kass D, Bond M, Niimura H, Schoen FJ, Conner D, Fischman DH, Seidman CE, Seidman JG: Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice. J Clin Invest 1999, 104:1235-1244
24. Fatkin D, Christe ME, Aristizabal O, McConnel BK, Srinivasan S, Schoen FJ, Seidman CE, Turnbull DH, Seidman JG: Neonatal cardiomyopathy in mice homozygous for the Arg403Gln mutation in the α cardiac myosin heavy chain gene. J Clin Invest 1999, 103:147-153
25. Mavroidis M, Capetanaki Y: Extensive induction of important mediators of fibrosis and dystrophic calcification in desmin-deficient cardiomyopathy. Am J Pathol 2002, 160:943-952
26. Eaton GJ, Custer RP, Johnson FN, Stabenow KT: Dystrophic cardiac calcinosis in mice: genetic, hormonal, and dietary influences. Am J Pathol 1978, 90:173-186
27. Everitt JI, Olson LM, Mangum JB, Viskek WJ: High mortality with severe dystrophic cardiac calcinosis in C3H/OUJ mice fed high fat purified diets. Vet Pathol 1988, 25:113-118
28. Gang DL, Barrett LV, Wilson EJ, Rubin RH, Medearis DN: Myopericarditis and enhanced dystrophic cardiac calcification in murine cytomegalovirus infection. Am J Pathol 1986, 124:207-215
29. Brunnert SR: Morphologic response of myocardium to freeze-thaw injury in mouse strains with dystrophic cardiac calcification. Lab Anim Sci 1997, 47:11-18
30. Ivandic BT, Qiao JH, Machleder D, Liao F, Drake TA, Lusis AJ: A locus on chromosome 7 determines myocardial cell necrosis and calcification (dystrophic cardiac calcinosis) in mice. Proc Natl Acad Sci USA 1996, 93:5483-5488
31. Gadeau A-P, Chaulet H, Daret D, Kockx M, Daniel-Lamaziere J-M, Desgranges C: Time course of osteopontin, osteocalcin, and osteonectin accumulation and calcification after acute vessel wall injury. J Histochem Cytochem 2001, 49:79-86
32. Winer J, Jung CKS, Shackel I, Williams PM: Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem 1999, 270:41-49
33. Graf K, Do YS, Ashizawa N, Meehan WP, Giachelli CM, Marboe CC, Fleck E, Hsueh WA: Myocardial osteopontin expression is associated with left ventricular hypertrophy. Circulation 1997, 96:3063-3071
34. Ono M, Yamamoto T, Nose M: Allelic difference in the nucleotide sequence of the Eta-1/Op gene transcript. Mol Immunol 1995, 32: 447-448
35. Miyazaki Y, Setoguchi M, Yoshida S, Higuchi Y, Akizuki S, Yamamoto S: The mouse osteopontin gene. Expression in monocytic lineages and complete nucleotide sequence. J Biol Chem 1990, 265:14432-14438
36. Denhardt DT, Guo X: Osteopontin: a protein with diverse functions. EMBO J 1993, 7:1475-1482
37. O'Regan A, Berman JS: Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation. Int J Exp Pathol 2000, 81:373-390
38. Giachelli CM, Steitz S: Osteopontin: a versatile regulator of inflammation and biomineralization. Matrix Biol 2000, 19:615-622
39. Noda M, Yoon K, Prince CW, Butler WT, Rodan GA: Transcriptional regulation of osteopontin production in rat osteosarcoma cells by type β transforming growth factor. J Biol Chem 1988, 263:13916-13921
40. Noda M, Rodan GA: Type β transforming growth factor regulates expression of genes encoding bone matrix proteins. Connect Tissue Res 1989, 21:71-75
41. Boström K, Demer LL: Regulatory mechanisms in vascular calcification. Crit Rev Eukaryot Gene Expr 2000, 12:151-158
42. Giachelli CM: Ectopic calcification. Gathering hard facts about soft tissue mineralization. Am J Pathol 1999, 154:671-675
43. Christoffersen J, Landis WJ: A contribution with review to the description of mineralization of bone and other calcified tissues in vivo. Anat Rec 1991, 230:435-450
44. Spicer SS, Lewis SE, Tashian RE, Schulte BA: Mice carrying a CAR-2 null allele lack carbonic anhydrase II immunohistochemically and show vascular calcification. Am J Pathol 1989, 134:947-954
45. Rittling SR, Denhardt DT: Osteopontin function in pathology: lessons from osteopontin-deficient mice. Exp Nephrol 1999, 7:103-113
46. Liaw L, Birk DE, Ballas CB, Whitsitt JS, Davidson JM, Hogan BL: Altered wound healing in mice lacking a functional osteopontin gene (spp1). J Clin Invest 1998, 101:1468-1478
47. McKee MD, Nanci A: Secretion of osteopontin by macrophages and its accumulation at tissue surfaces during wound healing in mineralized tissues: a potential requirement for macrophage adhesion and phagocytosis. Anat Rec 1996, 245:394-409
48. Yoshitake H, Rittling SR, Denhardt DT, Noda M: Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption. Proc Natl Acad Sci USA 1999, 96:8160-8165
49. Ivandic BT, Utz HF, Kaczmarek PM, Aherrahrou Z, Axtner SB, Klepsch C, Lusis AJ, Katus HA: New dyscalc loci for myocardial cell necrosis and calcification (dystrophic cardiac calcinosis) in mice. Physiol Genomics 2001, 6:137-144
50. Brunnert SR, Shi S, Chang B: Chromosomal localization of the loci responsible for dystrophic cardiac calcinosis in DBA/2 mice. Genomics 1999, 59:105-107
51. van den Broek FA, Bakker R, den Bieman M, Bouwman-Fielmich AX, Lemmens AG, van Lith HA, Nissen I, Hoitinga-Ritskes JM, van Tintelen G, van Zutphen LF: Genetic analysis of dystrophic cardiac calcification in DBA/2 mice. Biochem Biophys Res Commun 1998, 253:204-208
52. Colinayo VV, Qiao JH, Demant P, Krass K, Lusis AJ, Drake TA: Genetic characterization of the Dyscalc locus. Mamm Genome 2002, 13:283-288
53. Shi X, Bai S, Li L, Cao X: Hox-9 represses transforming growth factor-β-induced osteopontin gene transcription. J Biol Chem 2001, 276:850-855
54. Galvin KM, Donovan MJ, Lynch CA, Meyer RI, Paul RJ, Lorenz JN, Fairchild-Huntress V, Dixon KL, Dunmore JH, Gimbrone Jr MA, Falb D, Huszar D: A role for Smad6 in development and homeostasis of the cardiovascular system. Nat Genet 2000, 24:171-174
55. Speer MY, McKee MD, Guldberg RE, Liaw L, Yang H-S, Tung E, Karsenty G, Giachelli CM: Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla-protein deficient mice: evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo. J Exp Med 2002, 196:1047-1055
56. van Fleet JF, Ferrans VJ: Ultrastructural changes in inherited cardiac calcinosis of DBA/2 mice. Am J Vet Res 1987, 48:255-261